不稳定的铁池动力学不会在结肠直肠癌细胞中驱动铁
Varun Ponnusamy1, Deahzana R Randall1, Zheng Hong Lee2
1Department of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, MI, USA.
The Journal of biological chemistry
|March 12, 2026
概括
结肠直肠癌细胞经历铁亡,这是一种依赖铁的细胞死亡途径. 这项研究发现,虽然铁能促进铁,但在这个过程中,不稳定的铁池 (LIP) 不会增加.
科学领域:
- 生物化学 生物化学
- 细胞生物学 细胞生物学
- 在瘤学瘤学.
背景情况:
- 大肠直肠癌 (CRC) 是癌症死亡的主要原因.
- 红细胞核瘤积累铁,促进增殖,但有氧化损伤的风险.
- 铁,一种依赖于铁的细胞死亡,涉及由谷氨过氧化酶4 (GPX4) 调节的脂质过氧化.
研究的目的:
- 为了研究不稳定铁池 (LIP) 在铁亡中的作用.
- 为了确定LIP水平在CRC细胞中ferroptosis诱导期间是否发生变化.
主要方法:
- 结肠直肠癌细胞用铁和铁灭诱导剂 (RSL3,JKE1674) 进行治疗.
- 评估了铁调节者的基因表达.
- 使用两种独立的方法测量了不稳定铁水平.
主要成果:
- 外源铁补充剂降低了细胞活力,增强了铁亡.
- 尽管有铁的作用,但在通过GPX4或SLC7A11抑制诱导铁死时,LIP并没有显著增加.
- 铁调节基因表达没有显示出一致的变化.
结论:
- 在CRC细胞中药理学诱导的铁死不涉及扩大性铁池.
- 外源性铁会增强铁,但内源性LIP的动态在细胞死亡过程中有所不同.
相关概念视频
Electron Transport Chain: Complex I and II
11.9K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
11.9K
Drugs that Stabilize Microtubules
2.2K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.2K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Cancer Stem Cells and Tumor Maintenance
4.3K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.3K


